«You've got the
genes encoding for
resistance in the soil beneath these operations,» he says, «and we know that the
majority of the antibiotics animals consume get excreted intact.»
Despite these successes two major problems remain: first, the
majority of lung cancer patients have tumours without mutations in targetable
genes and; second, all patients eventually develop
resistance to treatment with these targeted agents.